Drug Type Gene therapy |
Synonyms |
Target |
Mechanism CNGB3 gene stimulants(Cyclic nucleotide-gated cation channel beta-3 gene stimulants) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization Beacon Therapeutics Ltd.Startup |
Active Organization- |
Inactive Organization Beacon Therapeutics Ltd.Startup |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Achromatopsia 1 | Preclinical | GB | Beacon Therapeutics Ltd.Startup | 16 Jun 2023 |